Title |
Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C
|
---|---|
Published in |
Cochrane database of systematic reviews, February 2014
|
DOI | 10.1002/14651858.cd005441.pub3 |
Pubmed ID | |
Authors |
Goran Hauser, Tahany Awad, Jesper Brok, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk, Christian Gluud, Lise Lotte Gluud |
Abstract |
Pegylated interferon (peginterferon) plus ribavirin is the recommended treatment for patients with chronic hepatitis C, but systematic assessment of the effect of this treatment compared with interferon plus ribavirin is needed. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 255 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | <1% |
Spain | 1 | <1% |
United Kingdom | 1 | <1% |
Unknown | 251 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 43 | 17% |
Student > Bachelor | 35 | 14% |
Student > Ph. D. Student | 27 | 11% |
Researcher | 22 | 9% |
Student > Doctoral Student | 13 | 5% |
Other | 45 | 18% |
Unknown | 70 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 88 | 35% |
Nursing and Health Professions | 26 | 10% |
Psychology | 20 | 8% |
Agricultural and Biological Sciences | 6 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 2% |
Other | 33 | 13% |
Unknown | 76 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2017.
All research outputs
#8,296,578
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#8,927
of 11,499 outputs
Outputs of similar age
#76,121
of 235,822 outputs
Outputs of similar age from Cochrane database of systematic reviews
#184
of 230 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 235,822 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 230 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.